Latest Lupin stock price

Lupin P/E Ratio

LUPIN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
23.23
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 23.23
Current Price ₹2219.40
EPS (TTM) ₹71.95
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 28.28
Historical Range 18.62 - 48.06
Percentile 33.3%

Sector Context

Sector Average 45.14
Sector Median 27.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹101.73
Sept 2025 ₹32.36
Mar 2025 ₹16.93

Key P/E Ratio Insights for Lupin

  • Trading at discount to sector average PE of 45.14

View the LUPIN equity price for detailed stock performance.

P/E Ratio Historical Trend for Lupin

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 23.25 101.73 ₹2364.90 NSE Moderate
2024 20.87 62.92 ₹1312.85 NSE Moderate
2023 18.62 39.36 ₹732.85 NSE Moderate
2020 30.44 25.33 ₹771.15 NSE High
2017 48.06 31.33 ₹1505.75 NSE High
2016 28.42 64.93 ₹1845.25 NSE High

Sector P/E Ratio Comparison

Comparing Lupin with other companies in Healthcare sector
Sector Average
45.14
Sector Median
27.5
Lowest P/E
1.24
Highest P/E
696.31
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.24 ₹43 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.46 ₹1,173 Low
Amwill Health Care AMWILL 6.88 ₹70 Low
Medicamen Organics MEDIORG 7.54 ₹31 Low
JFL Life Sciences JFLLIFE 8.22 ₹38 Low
Zenith Drugs ZENITHDRUG 8.22 ₹80 Low
Galaxy Medicare GML 8.51 ₹29 Low
Unichem Laboratories UNICHEMLAB 9.18 ₹2,643 Low
Natco Pharma NATCOPHARM 10.23 ₹15,971 Low